Compare Mirae Asset Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk | Very High | Very High |
Rating | 2.0 | 5.0 |
Min SIP Amount | ₹99 | ₹100 |
Expense Ratio | 1.93 | 1.86 |
NAV | ₹37.42 | ₹38.47 |
Fund Started | 11 Jun 2018 | 25 Jun 2018 |
Fund Size | ₹2770.84 Cr | ₹6455.55 Cr |
Exit Load | Exit load of 1% if redeemed within 1 year. | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
2.0
5.0
Min SIP Amount
₹99
₹100
Expense Ratio
1.93
1.86
NAV
₹37.42
₹38.47
Fund Started
11 Jun 2018
25 Jun 2018
Fund Size
₹2770.84 Cr
₹6455.55 Cr
Exit Load
Exit load of 1% if redeemed within 1 year.
Exit load of 1% if redeemed within 15 days.
1 Year | 0.28% | 0.60% |
3 Year | 20.67% | 26.13% |
5 Year | 14.60% | 16.47% |
1 Year
0.28%
0.60%
3 Year
20.67%
26.13%
5 Year
14.60%
16.47%
Equity | 99.46% | 97.87% |
Cash | 0.54% | 2.13% |
Equity
99.46%
97.87%
Cash
0.54%
2.13%
Top 10 Holdings |
|
|
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.44% |
Divi's Laboratories Ltd. | 8.57% |
Glenmark Pharmaceuticals Ltd. | 6.91% |
Apollo Hospitals Enterprise Ltd. | 5.80% |
Cipla Ltd. | 5.55% |
Lupin Ltd. | 5.23% |
Dr. Reddy's Laboratories Ltd. | 4.34% |
Aurobindo Pharma Ltd. | 4.24% |
Fortis Healthcare Ltd. | 4.22% |
Ipca Laboratories Ltd. | 3.46% |
Sun Pharmaceutical Industries Ltd. | 12.05% |
Cipla Ltd. | 7.90% |
Dr. Reddy's Laboratories Ltd. | 7.82% |
Divi's Laboratories Ltd. | 7.10% |
Mankind Pharma Ltd. | 6.44% |
Lupin Ltd. | 5.78% |
Aurobindo Pharma Ltd. | 5.19% |
Alkem Laboratories Ltd. | 3.66% |
Cohance Lifesciences Ltd. | 3.01% |
Syngene International Ltd. | 2.98% |
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 11 Jun 2018 | 25 Jun 2018 |
Description
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
11 Jun 2018
25 Jun 2018